Haemonetics HAE Gain (Loss) on Repurchase of Debt Instrument
Gain (Loss) on Repurchase of Debt Instrument at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnRepurchaseOfDebtInstrument.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's gain (loss) on repurchase of debt instrument.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Haemonetics's gain (loss) on repurchase of debt instrument?
- Haemonetics (HAE) reported gain (loss) on repurchase of debt instrument of $0 in Q1 2026.
- What does gain (loss) on repurchase of debt instrument mean?
- This reflects the difference between the carrying value of debt and the cash paid to retire it before maturity. A gain indicates debt was repurchased at a discount, while a loss indicates a premium was paid. It highlights management's active balance sheet management and opportunistic capital structure adjustments.